BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.10, revenue of $875M beats by $39.97M
Source: SeekingAlpha
2026-02-23 16:09:44 ET
Read the full article on Seeking Alpha
For further details see:
BioMarin Pharmaceutical Non-GAAP EPS of $0.46 misses by $0.10, revenue of $875M beats by $39.97M
BioMarin Pharmaceutical Inc.
NASDAQ: BMRN
BMRN Trading
1.42% G/L:
$61.46 Last:
407,629 Volume:
$60.85 Open:
BMRN Latest News
February 27, 2026 08:00:00 pm
U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
February 24, 2026 09:00:00 am
BioMarin to Participate in Four Upcoming Investor Conferences in March
BMRN Stock Data
$11,572,007,511
190,193,201
0.01%
214
N/A
Biotechnology & Life Sciences
Healthcare
US
San Rafael
